Selection of T Cell Epitopes Using an Integrative Approach Mette Voldby Larsen cand. scient. in...
-
date post
21-Dec-2015 -
Category
Documents
-
view
213 -
download
0
Transcript of Selection of T Cell Epitopes Using an Integrative Approach Mette Voldby Larsen cand. scient. in...
Selection of T Cell Epitopes Using an Integrative Approach
Mette Voldby Larsencand. scient. in biology
ph.d. student
Outline
Summary of biological processes preceding a CTL response
Summary of the methods available for predicting the processes
Case study: -Obtaining data, generating method, evaluating the method (small exercise – how to make Roc curves)
- What can you use the method for?
Predicting proteasomalcleavage
NetChop (Keşmir et al, 2002, Nielsen et al, 2005)
Artificial Neural Networks (ANN) trained on different kinds of data.
- NetChop 20S: Trained on in vitro data- NetChop C-term: Trained on 1110 MHC I ligands
SLYNTVATL
Output: All aa in a protein are assigned a value between 0 and 1. Low values correspond to low probability of cleavage, high values to high probability of cleavage.
N1 N2 N3 C
A 1,56 0,25 0,1 -0,55
C -0,05 0,01 0,02 0
D -1,37 -1,42 -1,83 -1,83
E -1,65 -0,02 -1,51 -1,58
F -1,03 0,45 1,05 2,52
G -0,28 -1,14 -1,70 -1,41
H -0,21 -0,33 0,23 -0,55
I 0,11 0,49 0,62 0,52
K 1,03 0,41 -0,09 0,45
L 0,50 -0,09 0,11 0,94
M 0,38 0,46 0,58 0,29
N 1,43 -0,69 -1,01 -1,33
P -1,43 -3,00 -0,22 0,09
Q -0,47 0,97 -0,39 -0,12
R 1,34 1,47 0,42 1,47
S 0,56 0,34 -0,11 -2,26
T 0,12 0,04 -0,43 -0,72
V 0,49 0,50 0,71 0,30
W -0,54 0,64 1,65 0,87
Y -0,50 0,67 1,80 2,91
Predicting TAP transport efficiency
...…
Peters et al, 2003
SLYNTVATL RSLYNTVATL
0.56-0.09+1.80+0.94 = 3.212.73
SLYNTVATL 2.97
The score for a given peptide is an average over the 9mer, 10mer
HLA-A HLA-BA1 B7
A2 B8
A3 B27
A24 B39
A26 B44
B58
B62
Predicting MHC class I binding
Different ANN predict binding affinity to different MHC class I supertypes
Output: Each peptide is assigned a value between 0 and 1. Low values correspond to low binding affinity, high values to high binding affinity.
In theory, integrating all three steps should lead to improved identification of peptides capable of eliciting CTL responses
Integration?
How should we do it?
Dataset
– 148 9meric epitopes collected from the SYFPEITHI Database
– 69 9meric epitopes collected from the Los Alamos HIV Database
-The epitopes were grouped according to which MHC class I they bind
- The complete aa sequence of each sourceprotein was found in Swiss-Prot
- All other 9mers in the proteins were considered to be nonepitopes
Collecting and combining the parameters
Hypothetical protein: MTSSAKRKMSPDNPDEGPSSKV
INT
?
?
?
?
?
?
?
?
?
?
?
?
?
?
ProteasomalcleavagePos1 Pos2 Pos3 Pos4 Pos5 Pos6 Pos7 Pos8 Pos9 TAP MHC-I Epi/nonepi
MTSSAKRKM 0,87 0,00 0,17 0,06 0,59 0,89 0,96 0,76 0,97 2,14 0,76 0
TSSAKRKMS 0,00 0,17 0,06 0,59 0,89 0,96 0,76 0,97 0,02 1,01 0,32 0
SSAKRKMSP 0,17 0,06 0,59 0,89 0,96 0,76 0,97 0,02 0,02 3,05 0,44 0
SAKRKMSPD 0,06 0,59 0,89 0,96 0,76 0,97 0,02 0,02 0,02 -0,02 0,21 0
AKRKMSPDN 0,59 0,89 0,96 0,76 0,97 0,02 0,02 0,02 0,00 2,22 0,54 0
KRKMSPDNP 0,89 0,96 0,76 0,97 0,02 0,02 0,02 0,00 0,01 -1,09 0,33 0
RKMSPDNPD 0,96 0,76 0,97 0,02 0,02 0,02 0,00 0,01 0,56 1,04 0,05 0
KMSPDNPDE 0,76 0,97 0,02 0,02 0,02 0,00 0,01 0,56 0,04 0,03 0,12 0
MSPDNPDEG 0,97 0,02 0,02 0,02 0,00 0,01 0,56 0,04 0,25 0,72 0,43 0
SPDNPDEGP 0,02 0,02 0,02 0,00 0,01 0,56 0,04 0,25 0,14 0,83 0,11 0
PDNPDEGPS 0,02 0,02 0,00 0,01 0,56 0,04 0,25 0,14 0,08 2,01 0,11 0
DNPDEGPSS 0,02 0,00 0,01 0,56 0,04 0,25 0,14 0,08 0,06 1,70 0,66 0
NPDEGPSSK 0,00 0,01 0,56 0,04 0,99 0,14 0,08 0,06 0,98 0,71 0,43 1
PDEGPSSKV 0,01 0,56 0,04 0,25 0,14 0,08 0,06 1,00 0,98 1,01 0,02 0
Threshold TP FN
TP/(TP+FN) FP TN
FP/(FP+TN)
>0,8 4 10 0,29 1 12 0,08
>0,6 8 6 0,57 3 10 0,23
>0,4 11 3 0,79 6 7 0,46
>0,2 13 1 0,93 9 4 0,69
>0 14 0 1 13 0 1
0
0,1
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1
0 0,1 0,2 0,3 0,4 0,5 0,6 0,7 0,8 0,9 1
False positives rate
True positives rate
AUC = 0.5AUC = 1.0
Practical use of NetCTL -ongoing projects
Prediction of epitopes in:HIV (collaboration with Karolinska Institute in Sweden)
Influenza A (collaboration with Panum institute)
Tuberculosis (collaboration with Leiden University in the Netherlands)
West nile virus (collaboration with Panum institute)
Yellow fever virus (collaboration with Panum institute)
Rickettsia (collaboration with Argentina)
Lassa/Junin virus (collaboration with Panum and Instituto Malbran, Argentina)